Oracle's AI Windfall Comes With a Debt Hangover That Won't Quit

Oracle's cloud revenue soars 93% and backlog hits $638B, but $130B debt and negative cash flow pressure the stock amid AI expansion.

There is a peculiar arithmetic at work inside Oracle right now. The company's order book has swollen to a staggering $638 billion, cloud infrastructure revenue is compounding at nearly double-digit speed, and yet the equity is down more than 40 percent over the past twelve months. The gap between those two realities — the commercial triumph and the financial strain — is the defining tension of the stock this summer.

The latest chapter unfolded in early August, when Oracle shares jumped 9.22 percent to $141.85 on the back of an expanded Google Cloud partnership, a fresh wave of contract wins, and persistent demand in the AI segment. The Google tie-up will see Gemini models integrated into Oracle's Fusion Applications and NetSuite platforms, orchestrated through the Oracle AI Agent Studio and supported by the Oracle AI Database running on Google Cloud. Days later came a roughly $400 million, ten-year engagement with CACI International to modernize federal HR systems for the US Office of Personnel Management, with CACI deploying Oracle Fusion HCM as a software-as-a-service solution alongside embedded AI capabilities, supported by Baker Tilly and Deloitte. Oracle Health also extended its footprint to hospitals in Ontario.

Those wins followed a July 23 framework agreement with the US Department of Defense under its Enterprise Software Initiative — a ten-year pact with a base value of $3.31 billion for the first five years, potentially expanding to $6.99 billion if all options are exercised. The contract consolidates what had been fragmented Oracle licensing across the military.

The order pipeline feeding these announcements is formidable. In the fiscal fourth quarter, total revenue rose 21 percent to $19.2 billion, while cloud infrastructure revenue surged 93 percent to $5.8 billion. Remaining Performance Obligations — the company's measure of contracted future work — jumped by $85 billion in the quarter to $638 billion, a 363 percent increase year over year. For the full fiscal year, Oracle posted revenue of $67.4 billion, up 17 percent, with cloud revenue climbing 39 percent to $34 billion. Management is guiding to $90 billion in revenue for fiscal 2027 and lifted its adjusted earnings forecast to $8.05 per share.

But here is where the story complicates. Funding that expansion has required extraordinary leverage. Capital expenditures shot up 162 percent to $55.7 billion in the fiscal year, driving free cash flow to negative $23.7 billion. Oracle added $43 billion in new debt and $5 billion in equity financing during the year, and has signaled roughly $40 billion more in capital raises for the current fiscal year. By late May, media reports put total debt near $130 billion. S&P Global responded in late July by downgrading the company to BBB- — one notch above junk territory.

The strain extends to the top of the organization. Founder and Chief Technology Officer Larry Ellison pledged 346 million Oracle shares as collateral for loans last June — a reminder of how closely personal exposure is tied to the corporate capital structure.

UBS analyst Karl Keirstead captured the prevailing ambivalence on August 6, trimming his price target to $245 from $285 while maintaining a Buy rating. He cited heavy AI infrastructure spending and tight credit market conditions, and pointed to the 27 percent share decline that followed the May earnings release. The message: the growth story remains credible, but the risk premium is climbing.

Market behavior reflects that split personality. The stock has been whipsawing — down 24.45 percent year to date and 41.35 percent over twelve months, trading more than 50 percent below its 52-week high of $294.85 reached last September. Annualized volatility of 58.18 percent underscores how sensitive trading has become to each new data point. In Frankfurt, the shares closed at €124.28 on Thursday, down 0.58 percent on the day but up 10.33 percent over seven days — evidence that the recent flow of contract announcements is resonating with investors even as the UBS target tempers enthusiasm.

The next test arrives September 7, when Oracle reports quarterly results. The question then will be whether the torrent of new contracts is beginning to close the cash flow gap — or whether the company must defend its infrastructure bet with yet more borrowed money. Oracle has chosen to compete at the front of the AI arms race; the bill for that ambition is now visible on the balance sheet.